Heart2Heart for Congenital Heart Disease

KF
Overseen ByKristen Fox, PhD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Kristen Fox
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to learn if teens living with congenital heart disease like and will use Heart2Heart and if it affects how they think and feel about e-cigarettes. Heart2Heart is a website that provides health information for teens with congenital heart disease. The main questions this trial aims to answer are:

* Will teens enroll in the trial and complete the trial activities?

* Do teens use and like Heart2Heart?

* Does using Heart2Heart affect how teens think and feel about e-cigarettes?

Researchers will compare the Heart2Heart group to a group that does not use Heart2Heart to see if it affects teens' thoughts and feelings about e-cigarettes.

Participants will:

* Complete online surveys

* If assigned, explore the Heart2Heart website

* If invited, share their opinions about Heart2Heart in an online discussion

Are You a Good Fit for This Trial?

This trial is for teens aged 12-18 who have been diagnosed with a structural congenital heart disease. If under 18, their parent or guardian must speak English or Spanish.

Inclusion Criteria

I am between 12 and 18 years old.
I am under 18 and my parent or guardian speaks English or Spanish well.
I have been diagnosed with a structural heart defect since birth.

Exclusion Criteria

Teen is leaving the United States during their study period
Teen was a participant in one of the Heart2Heart development studies
I do not have a device that can connect to the internet.
See 2 more

What Are the Treatments Tested in This Trial?

Interventions

  • Heart2Heart

Trial Overview

The study tests whether teens with congenital heart disease will use and like the Heart2Heart website, which gives health info. It also checks if using the site changes how they think about e-cigarettes compared to those who don't use it.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Heart2HeartExperimental Treatment1 Intervention
Group II: Treatment-as-UsualActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Kristen Fox

Lead Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Ohio State University

Collaborator

Trials
891
Recruited
2,659,000+